Southeast AIDS Education and Training Center (SE AETC) | 615-875-7873

Articles

Valpatasvir/sofobuvir; a panacea for HCV?

By: Takako Schaninger, MDAssociate Professor of Medicine | UK HealthCare This month, the FDA is expected to approve a new hepatitis C virus (HCV) drug. The once-daily, single-tablet, fixed-dose coformulation of velpatasvir and sofosbuvir is the latest addition to the...

read more